|
Progenics Pharmaceuticals |
|
|
777 Old Saw Mill River Road
Tarrytown, NY 10591 USA
phone:(914) 789-2800
fax:(914) 789-2817
|
|
| Symbol |
PGNX |
| Exchange |
NASDAQ |
| Founded |
0 |
| Employees |
|
|
|
| www.progenics.com
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Therapeutic products to treat debilitating & life-threatening conditions. |
|
| Management |
| Paul J. Maddon M.D., Ph.D., Founder, Chief Executive Officer and Chief Science Officer; Mark R. Baker J.D., President; Robert A. McKinney CPA, Senior Vice President, Finance and Operations & Chief Financial Officer and Treasurer; Thomas A. Boyd Ph.D., Senior Vice President, Product Development; Robert J. Israel M.D., Senior Vice President, Medical Affairs |
| |
|
|
|
|
|
|
|
| Keywords |
| methylnaltrexone, analgesics, constipation, gastrointestinal, monoclonal |
|
|
|
| Description |
|
Progenics Pharmaceuticals, Inc. is a biopharmaceutical company focusing on the development and commercialization of therapeutic products to treat the unmet medical needs of patients with debilitating conditions and life-threatening diseases Punk BUY |
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members
